The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine...

21
The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics

Transcript of The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine...

Page 1: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.

The Ethics of Performance Enhancing Drug Use

Jeffrey M. Anderson, MDDirector of Sports MedicineUConn Division of Athletics

Page 2: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.

So What Could Possibly Be Wrong With This?

Page 3: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.

Overview

Review of anabolic steroid structure/pharmacologic action

History of anabolic steroid use in sport

Ethical arguments surrounding anabolic steroid use in sport

Page 4: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.
Page 5: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.

Testosterone

Page 6: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.

Endogenous vs. Exogenous AAS

Endogenous– Testosterone– Androstenedione– Androstenediol– DHEA– 19-norandrosterone– 19-

noretiocholanolone

Exogenous– Nandrolone– Norandrostenedio

ne– Methandienone– Methyltestosteron

e– Stanozolol– Boldenone– Trenbolone

Page 7: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.

AAS Effects on muscle

Most potent stimulators of protein synthesis at the cellular level

Effects are noted with supraphysiologic doses (10x-100x)

Clearly have a positive effect on muscle growth and hypertrophy

Page 8: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.

History of AAS

Brown-Sequard 1889

Zoth and Pregl 1920s

Late 30s-testosterone synthesized by German scientists

1950s-Soviet use of testosterone in athletes

1960s-John Ziegler-Dianabol

Page 9: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.

History of AAS

1960s and 1970s-rampant use-not illegal or banned

1970s-GDR swimmers

Medical establishment still noted no benefit

Page 10: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.

History of AAS

1988-Ben Johnson +stanozolol test

1988-Underground Steroid Handbook-Duchaine

1991-Elashoff publishes review in Annals of Internal Medicine stating that no firm conclusion can be drawn on their effects

Page 11: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.

History of AAS

1996-Bhasin-first study documenting anabolic effects of steroids

Late 90s-Early 2000s—baseball

2004-US Anabolic Steroid Control Act

Page 12: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.

Side Effects of AAS

Hepatic– Liver injury

(temporary vs. permanent)

– Hepatic tumors Cardiac

– Lowered HDL, elevated LDL and triglycerides

– Increased thrombogenesis

– Cardiomyopathy

Genitourinary– Males

Impotence Oligospermia/

azoospermia Gynecomastia

– Females Clitoromegally Menstrual

disturbance Breast atrophy

Page 13: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.

Side Effects of AAS

Dermatologic– Acne– Male-pattern

baldness– Hirsutism

Musculoskeletal– Tendon rupture

Page 14: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.

Side Effects of AAS

Psychological– Aggressiveness– Rage– Delirium– Depression– Psychosis– Mania

Page 15: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.

How Common Are Side Effects? No controlled

trials Variation in

reports depending on perspective

Temporary vs. permanent?

GDR information is concerning

Page 16: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.

Ethics

Autonomy vs. paternalism Unnaturalness? Unfair advantage? Risk of harm?

– Personal harm vs. opponents harm vs. societal harm

Right to privacy

Page 17: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.

Autonomy– The principle of

respect for persons, and of individual self-determination consistent with that principle. As most commonly defined, autonomy points in the direction of personal liberty of action in accordance with a plan chosen only by oneself.

Paternalism– Stance that a

person’s liberty is justifiably restricted to prevent self-harm, or to promote that person’s own well-being. Paternalism is an inherently liberty-limiting principle. It is grounded in a theory of impairment, viz., that an individual lacks sufficient facts or mental capacity to make a sound choice.

Page 18: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.

Unnaturalness

AAS are an “unnatural” way to gain advantage

Are training, carbohydrate replacement, medications, etc. all “natural”?

Page 19: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.

Unfair Advantage

If one athlete uses steroids it gives them an unfair advantage

If steroids are not banned, everyone has access

Page 20: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.

Risk of harm

Harm to Self– Side effects

Harm to Others– What happens to that poor kid on

the previous slide? Harm to Society

– If one has to use steroids to compete fairly, how many will be forced into using them?

Page 21: The Ethics of Performance Enhancing Drug Use Jeffrey M. Anderson, MD Director of Sports Medicine UConn Division of Athletics.

Right to privacy

Drug testing procedure– Witnessed

collection– Complaints of

embarrassment– Lack of trust– Invasion of

privacy